TY - JOUR
T1 - The association of bile acid excretion and atherosclerotic coronary artery disease
AU - Charach, Gideon
AU - Grosskopf, Itamar
AU - Rabinovich, Alexander
AU - Shochat, Michael
AU - Weintraub, Moshe
AU - Rabinovich, Pavel
PY - 2011/3
Y1 - 2011/3
N2 - Background: Excess cholesterol is usually eliminated from the body by conversion to bile acids excreted in feces as bile salts. The excretion of large amounts of bile protects against atherosclerosis, while diminished excretion may lead to coronary artery disease (CAD). Objective: To investigate a relationship between CAD and bile acid excretion. Methods: Bile acid excretion was compared between 36 patients with proven CAD and 37 CAD-free individuals (controls). The groups were comparable for demographics and selected risk factors. All subjects received a 4-day standard diet that included ∼500 mg of cholesterol. Fecal bile acids from 24-hour stool collections were measured by gas liquid chromatography. Results: CAD patients excreted lower amounts of total bile acids (358∓156 mg) than controls (617∓293 mg; p < 0.01) and less deoxycholic acid (188.29∓98.12 mg versus 325.96∓198.57 mg; p < 0.0001) and less lithocholic acid (115.43∓71.89 mg versus 197.27∓126.87 mg; p < 0.01). Advanced age, male gender, left ventricular ejection fraction and total bile acid levels were significant independent factors that predicted CAD (p < 0.05). Mortality, CAD and cerebrovascular accident development rates were significantly lower for the controls at the 13-year follow up. Conclusion: CAD patients have significantly decreased bile acid excretion levels than non-CAD patients. An impaired ability to excrete cholesterol may be an additional risk factor for CAD development.
AB - Background: Excess cholesterol is usually eliminated from the body by conversion to bile acids excreted in feces as bile salts. The excretion of large amounts of bile protects against atherosclerosis, while diminished excretion may lead to coronary artery disease (CAD). Objective: To investigate a relationship between CAD and bile acid excretion. Methods: Bile acid excretion was compared between 36 patients with proven CAD and 37 CAD-free individuals (controls). The groups were comparable for demographics and selected risk factors. All subjects received a 4-day standard diet that included ∼500 mg of cholesterol. Fecal bile acids from 24-hour stool collections were measured by gas liquid chromatography. Results: CAD patients excreted lower amounts of total bile acids (358∓156 mg) than controls (617∓293 mg; p < 0.01) and less deoxycholic acid (188.29∓98.12 mg versus 325.96∓198.57 mg; p < 0.0001) and less lithocholic acid (115.43∓71.89 mg versus 197.27∓126.87 mg; p < 0.01). Advanced age, male gender, left ventricular ejection fraction and total bile acid levels were significant independent factors that predicted CAD (p < 0.05). Mortality, CAD and cerebrovascular accident development rates were significantly lower for the controls at the 13-year follow up. Conclusion: CAD patients have significantly decreased bile acid excretion levels than non-CAD patients. An impaired ability to excrete cholesterol may be an additional risk factor for CAD development.
KW - Atherosclerosis
KW - Bile acids
KW - Coronary artery disease
KW - High-density lipoprotein
KW - Low-density lipoprotein
UR - http://www.scopus.com/inward/record.url?scp=79953321818&partnerID=8YFLogxK
U2 - 10.1177/1756283X10388682
DO - 10.1177/1756283X10388682
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 21694811
AN - SCOPUS:79953321818
SN - 1756-283X
VL - 4
SP - 95
EP - 101
JO - Therapeutic Advances in Gastroenterology
JF - Therapeutic Advances in Gastroenterology
IS - 2
ER -